Viridian Shares Soar After Latest Trial Success for Thyroid Eye Disease Drug

Viridian Therapeutics' experimental treatment for chronic thyroid eye disease (TED) significantly reduced symptoms such as double vision and eye bulging in a late-stage...
Reuters Health Information